A new trading day began on Tuesday, with Neogenomics Inc. (NASDAQ: NEO) stock price up 2.49% from the previous day of trading ,before settling in for the closing price of $14.85. NEO’s price has ranged from $11.03 to $21.22 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 17.35% over the past five years. Meanwhile, its annual earnings per share averaged 97.05%. With a float of $126.12 million, this company’s outstanding shares have now reached $127.37 million.
Let’s look at the performance matrix of the company that is accounted for 2100 employees.
Neogenomics Inc. (NEO) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Neogenomics Inc. is 1.16%, while institutional ownership is 99.27%. The most recent insider transaction that took place on Mar 04 ’24, was worth 97,579. In this transaction Director of this company sold 6,112 shares at a rate of $15.97, taking the stock ownership to the 50,062 shares. Before that another transaction happened on Feb 15 ’24, when Company’s General Counsel sold 2,587 for $14.96, making the entire transaction worth $38,713. This insider now owns 34,866 shares in total.
Neogenomics Inc. (NEO) Performance Highlights and Predictions
In its latest quarterly report, released on 12/30/2023, the company reported earnings of $0.03 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 97.05% per share during the next fiscal year.
Neogenomics Inc. (NASDAQ: NEO) Trading Performance Indicators
Here are Neogenomics Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach 0.14 in one year’s time.
Technical Analysis of Neogenomics Inc. (NEO)
Neogenomics Inc. (NASDAQ: NEO) saw its 5-day average volume 0.6 million, a negative change from its year-to-date volume of 0.93 million. As of the previous 9 days, the stock’s Stochastic %D was 33.82%. Additionally, its Average True Range was 0.66.
During the past 100 days, Neogenomics Inc.’s (NEO) raw stochastic average was set at 19.46%, which indicates a significant decrease from 50.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.22% in the past 14 days, which was lower than the 57.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.24, while its 200-day Moving Average is $15.56. Nevertheless, the first resistance level for the watch stands at $15.56 in the near term. At $15.91, the stock is likely to face the second major resistance level. The third major resistance level sits at $16.24. If the price goes on to break the first support level at $14.88, it is likely to go to the next support level at $14.55. Assuming the price breaks the second support level, the third support level stands at $14.20.
Neogenomics Inc. (NASDAQ: NEO) Key Stats
With a market capitalization of 1.94 billion, the company has a total of 127,610K Shares Outstanding. Currently, annual sales are 591,640 K while annual income is -87,970 K. The company’s previous quarter sales were 155,550 K while its latest quarter income was -14,330 K.
